Edit |   |
---|---|
Antigenic Specificity | CD11a, Human (Efalizumab biosimilar) |
Clone | Efalizumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD11a Recombinant Antibody. Efalizumab (trade name Raptiva, Genentech, Merck Serono) is a formerly available medication designed to treat autoimmune diseases, originally marketed to treat psoriasis. As implied by the suffix -mab, it is a recombinant humanized monoclonal antibody administered once weekly by subcutaneous injection. |
Immunogen | n/a |
Other Names | Anti-CD11a Recombinant Antibody, Research Grade Efalizumab, Anti-Human CD11a Recombinant Antibody, hu1124, Antibody Drug Analogues, Monoclonal Antibody, YR1019, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 214745-43-4 |
Catalog # | YR1019 |
Price | please inquire |
Order / More Info | CD11a, Human (Efalizumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |